Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

被引：10

作者：

Herbst, Roy S. ^{[1
,2
]}

Baas, Paul ^{[3
,4
]}

Perez-Gracia, Jose L. ^{[5
]}

Felip, Enriqueta ^{[6
,7
]}

Kim, Dong-Wan ^{[8
]}

Han, Ji-Youn ^{[9
]}

Molina, Julian ^{[10
]}

Kim, Joo-Hang ^{[11
]}

Arvis, Catherine Dubos ^{[12
]}

Ahn, Myung-Ju ^{[13
]}

Majem, Margarita ^{[14
]}

Fidler, Mary Jo ^{[15
]}

Surmont, Veerle ^{[16
]}

De Castro, Gilberto, Jr. ^{[17
]}

Garrido, Marcelo ^{[18
]}

Shentu, Yue ^{[19
]}

Dolled-Filhart, Marisa ^{[19
]}

Im, Ellie ^{[19
]}

Garon, Edward B. ^{[20
]}

机构：

[1] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA

[2] Smilow Canc Hosp, New Haven, CT USA

[3] Netherlands Canc Inst, Amsterdam, Netherlands

[4] Acad Med Hosp, Amsterdam, Netherlands

[5] Clin Univ Navarra, Pamplona, Spain

[6] Vall dHebron Univ Hosp, Barcelona, Spain

[7] Vall dHebron Inst Oncol, Barcelona, Spain

[8] Seoul Natl Univ Hosp, Seoul, South Korea

[9] Natl Canc Ctr, Goyang, South Korea

[10] Mayo Clin, Rochester, MN USA

[11] CHA Univ, CHA Bundang Med Ctr, Pocheon Si, Gyeonggi Do, South Korea

[12] Ctr Francois Baclesse, Caen, France

[13] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[14] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[15] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[16] Univ Ziekenhuis Ghent, Ghent, Belgium

[17] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil

[18] Pontificia Univ Catolica Chile, Santiago, Chile

[19] Merck & Co Inc, Kenilworth, NJ USA

[20] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 10期

关键词：

biopsy; immunohistochemistry; PD-L1; pembrolizumab;

D O I：

10.1016/j.jtho.2016.08.112

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.41

引用

页码：S242 / S243

页数：3